Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Biotechnology

Health Care

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical's headquarters in Chapel Hill, NC, United States

Gustavo Pesquin

Jason Krentz

Ralph Herbst

Melissa Murrell

Josh Grieger

Canwen Jiang

Cara Davis

Candace Summerford

Amanda Lowder

R. Jude Samulski

Tracy Dowling

Wolfram Carius

Stefan Oelrich

Christian Rommel

The Leadership Team at Asklepios BioPharmaceutical is responsible for guiding the company's strategic vision and operational execution in the development of AAV gene therapies. This team, comprised of executives from various disciplines such as scientific research, development, finance, and intellectual property, collaborates to drive innovation, ensure regulatory compliance, and navigate the complex landscape of the biotechnology industry. Their collective expertise helps to advance the organization's mission of delivering transformative therapies for genetic disorders.

Leadership Team

The Business Development and Strategy team at Asklepios BioPharmaceutical focuses on identifying new market opportunities, forming strategic partnerships, and driving the commercialization of AAV gene therapies. They collaborate closely with clinical and operational teams to align business objectives with the company’s innovative pipeline, ensuring the successful delivery of therapies for genetic disorders.

Business Development and Strategy

The Clinical Operations team at Asklepios BioPharmaceutical is responsible for overseeing the planning, execution, and management of clinical trials for AAV gene therapies targeting neurodegenerative and rare diseases. This team collaborates with various stakeholders to ensure compliance with regulatory standards, manages trial logistics, and analyzes data to drive the development of innovative treatments, ultimately aiming to improve patient outcomes.

Clinical Operations

The Regulatory and Quality Assurance team at Asklepios BioPharmaceutical is responsible for ensuring compliance with regulatory standards and quality guidelines throughout the development and manufacturing processes of AAV gene therapies. This team collaborates with regulatory agencies to oversee the approval of clinical trials, while implementing Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Manufacturing Practice (GMP) to maintain the highest quality and safety standards for genetic therapies.

Asklepios BioPharmaceutical

Org chart

Board & advisors

Teams

Leadership Team

Business Development and Strategy

Clinical Operations

Regulatory and Quality Assurance

Offices

Asklepios BioPharmaceutical

Org chart

Board & advisors

Teams

Leadership Team

Business Development and Strategy

Clinical Operations

Regulatory and Quality Assurance

Offices

Related companies